- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/11 | 0.23 | -10.43 | -5.37 | 2.58 | 12.39 | 0.69 | N/A | - | ||
2024/10 | 0.26 | 26.65 | 17.31 | 2.35 | 14.51 | 0.74 | N/A | - | ||
2024/9 | 0.2 | -27.82 | -6.08 | 2.09 | 14.17 | 0.69 | 0.22 | - | ||
2024/8 | 0.28 | 40.19 | 34.15 | 1.88 | 16.9 | 0.96 | 0.16 | - | ||
2024/7 | 0.2 | -57.64 | 18.28 | 1.6 | 14.31 | 0.92 | 0.16 | - | ||
2024/6 | 0.48 | 98.71 | 30.03 | 1.4 | 13.76 | 0.92 | 0.17 | - | ||
2024/5 | 0.24 | 15.05 | 6.5 | 0.92 | 6.88 | 0.61 | 0.26 | - | ||
2024/4 | 0.21 | 24.14 | 39.46 | 0.69 | 7.01 | 0.53 | 0.3 | - | ||
2024/3 | 0.17 | 11.05 | -18.85 | 0.48 | -2.84 | 0.48 | 0.8 | - | ||
2024/2 | 0.15 | -4.98 | -26.38 | 0.31 | 8.77 | 0.66 | 0.57 | - | ||
2024/1 | 0.16 | -55.21 | 99.2 | 0.16 | 99.2 | 0.76 | 0.5 | 因去年1月適逢農曆春節工作天數較少,故營業額較去年同期增加所致。 | ||
2023/12 | 0.35 | 45.13 | 32.34 | 2.65 | 12.21 | 0.82 | 0.31 | - | ||
2023/11 | 0.24 | 11.03 | -8.25 | 2.29 | 9.63 | 0.68 | 0.37 | - | ||
2023/10 | 0.22 | 1.39 | 38.03 | 2.05 | 12.24 | 0.65 | 0.39 | - | ||
2023/9 | 0.22 | 3.1 | 12.38 | 1.83 | 9.77 | 0.6 | 0.3 | - | ||
2023/8 | 0.21 | 23.6 | -3.72 | 1.61 | 9.43 | 0.75 | 0.24 | - | ||
2023/7 | 0.17 | -53.43 | -8.34 | 1.4 | 11.72 | 0.76 | 0.24 | - | ||
2023/6 | 0.37 | 62.75 | 61.08 | 1.23 | 15.21 | 0.74 | 0.16 | 本月儀器設備銷售額增加 | ||
2023/5 | 0.22 | 50.66 | 25.35 | 0.86 | 2.83 | 0.58 | 0.21 | - | ||
2023/4 | 0.15 | -27.77 | -5.19 | 0.64 | -3.26 | 0.56 | 0.21 | - | ||
2023/3 | 0.21 | 0.75 | -5.67 | 0.49 | -2.65 | 0.49 | 0.33 | - | ||
2023/2 | 0.2 | 157.13 | 32.84 | 0.28 | -0.34 | 0.55 | 0.29 | - | ||
2023/1 | 0.08 | -70.25 | -39.32 | 0.08 | -39.32 | 0.61 | 0.26 | - | ||
2022/12 | 0.27 | 0.61 | 46.83 | 2.36 | 3.66 | 0.69 | 0.22 | - | ||
2022/11 | 0.27 | 67.03 | 14.25 | 2.09 | -0.1 | 0.62 | 0.24 | - | ||
2022/10 | 0.16 | -17.44 | -6.35 | 1.82 | -1.9 | 0.57 | 0.26 | - | ||
2022/9 | 0.19 | -11.67 | -5.54 | 1.67 | -1.45 | 0.6 | 0.23 | - | ||
2022/8 | 0.22 | 17.67 | 5.22 | 1.47 | -0.88 | 0.63 | 0.22 | - | ||
2022/7 | 0.19 | -18.17 | -0.05 | 1.25 | -1.88 | 0.59 | 0.24 | - | ||
2022/6 | 0.23 | 26.65 | 16.25 | 1.07 | -2.19 | 0.56 | 0.25 | - | ||
2022/5 | 0.18 | 13.94 | 13.41 | 0.84 | -6.21 | 0.56 | 0.25 | - | ||
2022/4 | 0.16 | -28.13 | -37.03 | 0.66 | -10.4 | 0.53 | 0.26 | - | ||
2022/3 | 0.22 | 41.9 | 4.4 | 0.5 | 3.19 | 0.5 | 0.24 | - | ||
2022/2 | 0.15 | 17.44 | 23.96 | 0.29 | 2.28 | 0.47 | 0.26 | - | ||
2022/1 | 0.13 | -28.0 | -15.14 | 0.13 | -15.14 | 0.55 | 0.22 | - | ||
2021/12 | 0.18 | -21.7 | -41.69 | 2.28 | -23.85 | 0.59 | 0.19 | - | ||
2021/11 | 0.23 | 36.91 | 2.52 | 2.09 | -21.76 | 0.61 | 0.18 | - | ||
2021/10 | 0.17 | -16.73 | -44.2 | 1.86 | -24.02 | 0.58 | 0.19 | - | ||
2021/9 | 0.2 | -1.61 | -15.87 | 1.69 | -21.15 | 0.6 | 0.22 | - | ||
2021/8 | 0.21 | 11.77 | -1.47 | 1.49 | -21.82 | 0.59 | 0.22 | - | ||
2021/7 | 0.19 | -4.8 | -6.4 | 1.28 | -24.36 | 0.54 | 0.24 | - | ||
2021/6 | 0.2 | 23.55 | 13.41 | 1.09 | -26.75 | 0.6 | 0.17 | - | ||
2021/5 | 0.16 | -36.73 | -24.12 | 0.9 | -32.0 | 0.62 | 0.16 | - | ||
2021/4 | 0.25 | 19.14 | 25.38 | 0.74 | -33.47 | 0.58 | 0.17 | - | ||
2021/3 | 0.21 | 68.47 | -46.15 | 0.49 | -46.34 | 0.49 | 0.31 | - | ||
2021/2 | 0.12 | -19.6 | -67.69 | 0.28 | -46.49 | 0.59 | 0.25 | 因去年同期儀器設備銷售額增加,導致本月較去年同期營收減少 | ||
2021/1 | 0.15 | -50.52 | 13.19 | 0.15 | 13.19 | 0.7 | 0.22 | - | ||
2020/12 | 0.31 | 37.66 | 55.78 | 2.99 | -13.78 | 0.85 | 0.17 | 因本月儀器設備銷售額增加,導致本月營收較去年同期增加 | ||
2020/11 | 0.23 | -25.49 | -2.54 | 2.68 | -18.06 | 0.78 | 0.18 | - | ||
2020/10 | 0.31 | 25.55 | 56.08 | 2.45 | -19.26 | 0.76 | 0.18 | 因取得客戶之儀器設備訂單於10月完成驗收,導致本月營收增加 | ||
2020/9 | 0.24 | 15.23 | 29.38 | 2.14 | -24.45 | 0.65 | 0.32 | - | ||
2020/8 | 0.21 | 6.17 | 1.59 | 1.9 | -28.26 | 0.58 | 0.36 | - | ||
2020/7 | 0.2 | 15.35 | -8.04 | 1.69 | -30.8 | 0.58 | 0.36 | - | ||
2020/6 | 0.17 | -17.34 | -7.19 | 1.49 | -33.01 | 0.58 | 0.26 | - | ||
2020/5 | 0.21 | 4.54 | -72.24 | 1.32 | -35.36 | 0.8 | 0.19 | 因去年同期客戶新建醫療園區購置相關儀器設備陸續結案所致 | ||
2020/4 | 0.2 | -48.83 | -57.64 | 1.11 | -13.9 | 0.97 | 0.15 | 因去年同期生技園區實驗動物相關儀器設備需求增加所致 | ||
2020/3 | 0.39 | 1.08 | 90.07 | 0.91 | 11.2 | 0.91 | 0.16 | 因取得客戶之儀器設備訂單於3月完成驗收,導致本月營收增加 | ||
2020/2 | 0.39 | 181.67 | 1.56 | 0.52 | -15.08 | 0.72 | 0.21 | - | ||
2020/1 | 0.14 | -31.91 | -41.91 | 0.14 | -41.91 | 0.0 | N/A | - | ||
2019/12 | 0.2 | -13.88 | -34.55 | 3.47 | 18.03 | 0.0 | N/A | - |
年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
---|---|---|---|---|---|---|---|---|---|
2024/1 | 0.16 | 2023/1 | 0.08 | 2022/1 | 0.13 | 2021/1 | 0.15 | 2020/1 | 0.14 |
2024/2 | 0.15 | 2023/2 | 0.2 | 2022/2 | 0.15 | 2021/2 | 0.12 | 2020/2 | 0.39 |
2024/3 | 0.17 | 2023/3 | 0.21 | 2022/3 | 0.22 | 2021/3 | 0.21 | 2020/3 | 0.39 |
2024/4 | 0.21 | 2023/4 | 0.15 | 2022/4 | 0.16 | 2021/4 | 0.25 | 2020/4 | 0.2 |
2024/5 | 0.24 | 2023/5 | 0.22 | 2022/5 | 0.18 | 2021/5 | 0.16 | 2020/5 | 0.21 |
2024/6 | 0.48 | 2023/6 | 0.37 | 2022/6 | 0.23 | 2021/6 | 0.2 | 2020/6 | 0.17 |
2024/7 | 0.2 | 2023/7 | 0.17 | 2022/7 | 0.19 | 2021/7 | 0.19 | 2020/7 | 0.2 |
2024/8 | 0.28 | 2023/8 | 0.21 | 2022/8 | 0.22 | 2021/8 | 0.21 | 2020/8 | 0.21 |
2024/9 | 0.2 | 2023/9 | 0.22 | 2022/9 | 0.19 | 2021/9 | 0.2 | 2020/9 | 0.24 |
2024/10 | 0.26 | 2023/10 | 0.22 | 2022/10 | 0.16 | 2021/10 | 0.17 | 2020/10 | 0.31 |
2024/11 | 0.23 | 2023/11 | 0.24 | 2022/11 | 0.27 | 2021/11 | 0.23 | 2020/11 | 0.23 |
N/A | N/A | 2023/12 | 0.35 | 2022/12 | 0.27 | 2021/12 | 0.18 | 2020/12 | 0.31 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
合約負債 QoQ YoY | |||
---|---|---|---|
24Q3 (20) | 0.02 | 100.0 | -84.62 |
24Q2 (19) | 0.01 | -87.5 | -90.0 |
24Q1 (18) | 0.08 | 0.0 | 0.0 |
23Q4 (17) | 0.08 | -38.46 | 100.0 |
23Q3 (16) | 0.13 | 30.0 | 225.0 |
23Q2 (15) | 0.1 | 25.0 | 150.0 |
23Q1 (14) | 0.08 | 100.0 | 166.67 |
22Q4 (13) | 0.04 | 0.0 | 33.33 |
22Q3 (12) | 0.04 | 0.0 | 33.33 |
22Q2 (11) | 0.04 | 33.33 | 100.0 |
22Q1 (10) | 0.03 | 0.0 | -50.0 |
21Q4 (9) | 0.03 | 0.0 | 0.0 |
21Q3 (8) | 0.03 | 50.0 | 0.0 |
21Q2 (7) | 0.02 | -66.67 | -33.33 |
21Q1 (6) | 0.06 | 100.0 | 100.0 |
20Q4 (5) | 0.03 | 0.0 | 50.0 |
20Q3 (4) | 0.03 | 0.0 | 0.0 |
20Q2 (3) | 0.03 | 0.0 | 0.0 |
20Q1 (2) | 0.03 | 50.0 | 0.0 |
19Q4 (1) | 0.02 | 0.0 | 0.0 |